SINTX Taps Invibio Executive Ryan Elmore as President to Drive Biomaterials Expansion
Event summary
- Ryan Elmore, former Core Business Director at Invibio, appointed President of SINTX Technologies effective March 16, 2026.
- Elmore will lead commercialization of SiNERGY™ silicon nitride devices and antipathogenic fibrous material technologies.
- SINTX aims to expand beyond implants into sutures, mesh, wound dressings, and other textile-based applications.
- Company is developing multiple material forms including 3D-printable filament, extruded rod, and sheet stock.
The big picture
SINTX is pivoting from a product-focused medical device manufacturer to a broader biomaterials platform company, leveraging its proprietary silicon nitride expertise. This shift aligns with industry trends toward advanced materials in healthcare, where cross-category applications can drive significant revenue growth. The appointment of Elmore signals intent to scale commercialization through disciplined execution and strategic partnerships.
What we're watching
- Commercial Execution
- How Elmore's track record in biomaterials will translate to SINTX's platform strategy.
- Market Diversification
- The pace at which SINTX can expand into non-implantable medical applications.
- Partnership Dynamics
- Whether strategic alliances will accelerate adoption of silicon nitride technologies.